Patent ID: 7078541

Claim:
A compound represented by Formula II: wherein: R 6 : hydrogen, optionally substituted (C 1 –C 8 )-alkyl, optionally substituted (C 2 –C 10 ) -alkenyl, optionally substituted aryl, (optionally substituted (C 1 –C 8 ) -alkoxy)carbonyl, or halogen; R 7 and R 8 are independently selected from optionally substituted (C 1 –C 6 )-alkyl, optionally substituted (C 2 –C 10 )-alkenyl, or optionally substituted (C 3 –C 8 )-cycloalkyl; R 9 is: optionally substituted aryl, (optionally substituted(C 1 –C 8 )- alkyl)carbonyl, (optionally substituted aryl)carbonyl, (optionally substituted heterocyclyl)carbonyl, (optionally substituted heterocyclylalkyl)carbonyI, (optionally substituted (C 1 –C 8 ) -alkoxy)carbonyl, (optionally substituted (C 2 –C 10 )-alkenyloxy)carbonyl, (optionally substituted amino)carbonyl, carboxy, formyl, or hydroxy(optionally substituted)(C 1 –C 8 )-alkyl; R 10 is: (C 1 –C 6 )-alkyl, (C 2 –C 10 )-alkenyl, or amino; and R′is: hydrogen, (C 1 –C 6 )-alkyl, (C 1 -C 6 )-alkylcarbonyl, phosphoryl, or polyalkoxy; or R′and R 8 with the atoms to which they are attached form an optionally substituted ring; with the proviso that the compound is not (5-hydroxy-3,6,7-trimethyl-benzofuran-2-yl)-phenyl -methanone or 3-amino-5-hydroxy4,6,7-trimethyl-benzofuran-2-carboxylic acid ethyl ester; and single stereoisomers, mixtures of stereoisomers, and the pharmaceutically acceptable salts thereof.